EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanozymes in Upper Respiratory Tract Infections: Catalytic Mechanisms, Current Evidence, and Emerging Theranostic Strategies

Jingjing Huang iD, Zhuyu Han, Yang Liu, Jiechao Yang, Jiafu Liu, Yiwen Tao, Fangyong Zhu, Zelda Ziyi Zhao iD

ACS Biomaterials Science & Engineering · 09.11.2026 · 12 (11) · 6054-6066

DOI: 10.1021/acsbiomaterials.6c01534 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 08.10.2026. Verfasst von Jingjing Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wuxi Medical College of Jiangnan University , Wuxi, Jiangsu214122, China. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Theranostic Nanomedicine, Nanostructures, Biocompatible Materials. Die Arbeit nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This review evaluates nanozymes as catalytic biomaterials for upper respiratory tract infection (URTI)-related diagnosis, therapy, and prevention, with particular attention to differences in the maturity of evidence across these applications. The anatomically adjacent middle ear is also considered as a relevant model of biofilm-associated infection and barrier-limited local delivery.

Methods

We reviewed studies involving respiratory pathogens, sinonasal disease, pharyngitis, intranasal vaccination, and otitis media. Evidence from other disease models was included only when it addressed a specific materials problem relevant to the upper airway, such as catalytic regulation, biofilm disruption, mucus transport, or local retention.

Results

Diagnostic applications currently have the strongest evidence base, particularly for catalytic signal amplification in respiratory pathogen assays. In contrast, therapeutic evidence remains sparse and predominantly preclinical, with direct treatment studies in URTIs especially limited. Preventive applications are less extensively studied and are represented mainly by proof-of-concept intranasal influenza vaccination. Across these applications, performance depends on catalytic activity in protein- and mucus-rich media, biofilm penetration, control of pro-oxidant and antioxidant effects, and delivery to the intended anatomical site. Evidence from other anatomical sites provides useful design principles but should not be interpreted as evidence of efficacy in URTIs.

Conclusion

Nanozymes should currently be regarded as engineerable catalytic biomaterials rather than clinically established anti-infective platforms for URTIs. Translation will require reproducible activity in airway-relevant environments, effective site-specific delivery, appropriate safety margins, and validation in disease-relevant models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsTheranostic NanomedicineNanostructuresBiocompatible MaterialsHumansAnimalsCatalysisBiofilms

Stichwörter der Autor:innen

biofilmcatalytic therapydrug deliverymucosal biomaterialsnanozymesupper respiratory tract infections

Substanzen

Biocompatible Materials

Autor:innen und Institutionen

  • Wuxi Medical College of Jiangnan University , Wuxi, Jiangsu214122, China.
  • Department of Stomatology, Wuxi Medical Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Nanjing Medical University, Wuxi People's Hospital, Wuxi, Jiangsu214023, China.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Jiangnan University Medical Center (Wuxi No 2 People's Hospital), Wuxi, Jiangsu214002, China.
  • Shanxi Medical University , Taiyuan, Shanxi030001, China.
  • Department of Stomatology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu214122, China.

ORCID-Profile: Jingjing Huang, Zelda Ziyi Zhao

Zitieren

APA

Huang, J., Han, Z., Liu, Y., Yang, J., Liu, J., Tao, Y., Zhu, F., & Zhao, Z. Z. (2026). Nanozymes in Upper Respiratory Tract Infections: Catalytic Mechanisms, Current Evidence, and Emerging Theranostic Strategies. ACS Biomaterials Science & Engineering, 12(11), 6054-6066. https://doi.org/10.1021/acsbiomaterials.6c01534

Vancouver

Huang J, Han Z, Liu Y, Yang J, Liu J, Tao Y, et al. Nanozymes in Upper Respiratory Tract Infections: Catalytic Mechanisms, Current Evidence, and Emerging Theranostic Strategies. ACS Biomaterials Science & Engineering. 2026;12(11):6054-6066. doi:10.1021/acsbiomaterials.6c01534

BibTeX
@article{Huang2026,
  author = {Huang, Jingjing and Han, Zhuyu and Liu, Yang and Yang, Jiechao and Liu, Jiafu and Tao, Yiwen and Zhu, Fangyong and Zhao, Zelda Ziyi},
  title = {Nanozymes in Upper Respiratory Tract Infections: Catalytic Mechanisms, Current Evidence, and Emerging Theranostic Strategies},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {6054--6066},
  doi = {10.1021/acsbiomaterials.6c01534}
}
Kostenlos starten →